← Back to Clinical Trials
Recruiting NCT07058727

NCT07058727 Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07058727
Status Recruiting
Phase
Sponsor Cukurova University
Condition Efficacy of Hemostatic Agents
Study Type INTERVENTIONAL
Enrollment 75 participants
Start Date 2025-05-01
Primary Completion 2025-11-01

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Sodium Hypochlorite 2,5%ChlorhexidineCold Saline

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 75 participants in total. It began in 2025-05-01 with a primary completion date of 2025-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months

Eligibility Criteria

Inclusion Criteria: * Permanent teeth with carious pulp exposure (no spontaneous pain). * Positive vitality test (Endo-Ice). * No periapical radiolucency. Exclusion Criteria: * Systemic diseases affecting healing. * Pregnancy. * Non-vital pulp/necrosis

Frequently Asked Questions

Who can join the NCT07058727 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 55 Years, studying Efficacy of Hemostatic Agents. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07058727 currently recruiting?

Yes, NCT07058727 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cukurova University to inquire about joining.

Where is the NCT07058727 trial being conducted?

This trial is being conducted at Adana, Turkey (Türkiye).

Who is sponsoring the NCT07058727 clinical trial?

NCT07058727 is sponsored by Cukurova University. The trial plans to enroll 75 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology